NEW

Study Confirms Surfacide UV-C Kills SARS-CoV-2

A recent peer-reviewed study in the Journal of Clinical Anesthesia* found the Surfacide Helios® System UV-C technology is nearly 95% effective in preventing SARS CoV-2 in patient environments. This is the first clinical study that evaluates the use of UV-C in...

AORN Recommends Nasal Decolonization with PVP-I

The Association of periOperative Registered Nurses (AORN) has announced its annual updated recommendations on the "Guideline for Preoperative Skin Antisepsis," to assist health care professionals in navigating risk-based decisions for developing preoperative...

New AAAHC Quality Roadmap Probes Data, Highlights Surveyor Insights

On June 16, AAAHC released its 2021 Quality Roadmap, a comprehensive analysis of data from more than 1,120 accreditation surveys conducted in 2020.

RSIP Vision Reveals New Module

RSIP Vision has announced its new surgical workflow analysis technology, which can intelligently identify each separate stage of a surgical procedure and label them accordingly throughout the duration of the procedure.

Metrex Surface Disinfectant Portfolio Secures EPA Approval

Metrex Surface Disinfectant Portfolio Secures EPA Approval

The U.S. Environmental Protection Agency (EPA) has approved all eight surface disinfectant products made by an infection prevention leader, Metrex, as effective against SARS-CoV-2, the novel coronavirus that causes COVID-19.

The new claim was approved based on third-party laboratory testing results that support Metrex’s portfolio of broad-spectrum surface disinfectants to be effective against SARS-CoV-2 according to EPA Product Performance Test Guidelines Disinfectants for Use on Environmental Surfaces, Guidance for Efficacy Testing (OCSPP 810.2200).

“Healthcare professionals find themselves working in rapidly-evolving and complex conditions that have increased the demands of infection control,” said James Chia, Director of Research and Development at Metrex. “The below Metrex’s surface disinfection products are effective against SARS-CoV-2, helping to give front-line workers peace of mind that our products are protecting their patients and themselves.”

The following Metrex products have been approved by the EPA for efficacy against

SARS-CoV-2 and are on the EPA list N for use against SARS-CoV-2:

  • CaviWipes 2.0
  • CaviWipes
  • CaviWipes1
  • CaviWipes Bleach
  • CaviCide
  • CaviCide1
  • MetriGuard
  • EnviroCide

CaviWipes and CaviCide surface disinfectant products clean and disinfect hard, non-porous, inanimate surfaces and non-critical medical device surfaces in hospitals, laboratories and other clinical care environments. Formulated to kill a broad spectrum of bacteria, viruses and pathogenic fungi quickly and efficiently, CaviWipes and CaviCide branded products support kill times from one to three minutes.

For more information, visit www.metrex.com.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X